01 / Contract Profile
75A50123C00056 Federal Contract Award
Agency code 7505
DEOBLIGATE FUNDS FROM CLIN 0006/OPTION 5 PERTAINING TO RNA DEVELOPMENT RELATED EFFORTS; EXTEND POP FOR CLIN 0006 UNTIL FEBRUARY 28, 2027; UPDATE WORK ON SOW FOR CLIN 0001 AND CLIN 0006; UPDATE FIXED PRICE SUBCONTRACT TO $350,000; UPDATE KEY PERSONNEL
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75A50123C00056 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations-$6.53M
FY 2025Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2023 | $59.00M | 1 | — |
| FY 2024 | $51.05M | 3 | −13.5% |
| FY 2025 | -$6.53M | 2 | −112.8% |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | BARDA - ASPR / DAAPPO / BARDA DCMA |
05 / Contractor
Who holds this federal contract?
MODEX THERAPEUTICS LLC
UEI CDVMNSMRDTW8 · CAGE 8TB78
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $103.52M | 6 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN13 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $103.52M | 6 | 100.0% |
08 / Place of Performance
Where is the work recorded?
NATICK, MIDDLESEX, MASSACHUSETTS, UNITED STATES
ZIP 017602434
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Dec 23, 2025 | P00005 | -$6.53M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Mar 18, 2025 | P00004 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Oct 22, 2024 | P00003 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Sep 27, 2024 | P00002 | $35.00M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Sep 11, 2024 | P00001 | $16.05M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Sep 27, 2023 | Base action | $59.00M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.